Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01985932 · ClinicalTrials.gov registry record · NA

Functional MRI Use in Prostate Radiation Treatment Planning

A NA study, sponsored by Abramson Cancer Center at Penn Medicine.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT01985932 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01985932, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

This study is being done to evaluate the use of MRI during radiation treatment planning to identify areas of tumor within the prostate to aid in future treatment planning and targeting of prostate cancer. This study will be conducted at the University of Pennsylvania Health System. The study is projected to run for 18 months. Subjects will be male 18 or older with a prostate cancer diagnosis and treatment plansat the Department of Radiation Oncology.

Interventions

  • DEVICE MRI

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2012-07
Est. Completion 2015-12
Phase NA

What the Registry Record Tells You About NCT01985932

The ClinicalTrials.gov registry entry for NCT01985932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.

NCT01985932 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01985932 about?

NCT01985932 is a clinical study titled "Functional MRI Use in Prostate Radiation Treatment Planning". This study is being done to evaluate the use of MRI during radiation treatment planning to identify areas of tumor within the prostate to aid in future treatment planning and targeting of prostate cancer. This study will be conducted at the University of Pennsylvania Health System. The study is proj...

What is the current status of trial NCT01985932?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2012-07. Estimated completion is 2015-12.

What interventions are being tested in trial NCT01985932?

The interventions under investigation include: MRI (DEVICE).

Who is sponsoring clinical trial NCT01985932?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.